Abbott Laboratories Reports Strong Growth in Diagnostics Segment with 41.8% Quarter-over-Quarter Increase
Abbott Laboratories reported strong performance driven primarily by its diagnostics segment, which saw a significant quarter-over-quarter growth of 41.8%. The company also beat on revenue and EPS while raising full-year profit guidance for FY26.
Tickers: $ABT
Topics: Earnings Profit Guidance Revenue Growth